The effect of in utero ethinyl oestradiol exposure on the risk of cryptorchid testis and testicular teratoma in mice
1990

Effects of Ethinyl Oestradiol on Testicular Development in Mice

Sample size: 241 publication Evidence: moderate

Author Information

Author(s): A.H. Walker, L. Bernstein, D.W. Warren, N.E. Warner, X. Zheng, B.E. Henderson

Primary Institution: University of Southern California

Hypothesis

Does in utero exposure to ethinyl oestradiol increase the risk of cryptorchid testis and testicular teratoma in male mice?

Conclusion

The study found that exposure to ethinyl oestradiol before day 13 of gestation increases the risk of cryptorchid testis in male offspring and may also increase the risk of testicular teratomas.

Supporting Evidence

  • Ethinyl oestradiol exposure before day 13 of gestation significantly increased the likelihood of cryptorchid testis.
  • An increased incidence of testicular teratomas was observed in the ethinyl oestradiol treated groups, although not statistically significant.
  • 81% of cryptorchid testis cases were found in mice with pigmented tail-tips.

Takeaway

Giving pregnant mice a hormone called ethinyl oestradiol can make their baby boys more likely to have undescended testicles and possibly tumors.

Methodology

Pregnant mice were given ethinyl oestradiol injections before day 13 of gestation, and the offspring were examined for cryptorchidism and teratomas.

Potential Biases

Potential bias due to the inbred nature of the mouse strain and the controlled experimental conditions.

Limitations

The study was conducted on a specific mouse strain, which may limit the generalizability of the findings to other populations.

Participant Demographics

Inbred 129 Sv-S1 C P mice were used in the study.

Statistical Information

P-Value

0.0001

Confidence Interval

(0.9-13.2)

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication